… COVID-19 cases, they often have milder disease than adults and deaths have been extremely
rare. Diagnostic findings have been similar to adults, … of antiviral treatment of COVID-19 in …

… Greg Martin is a member of the NIH COVID-19 treatment … adults with COVID-19, we suggest
against the routine use of convalescent plasma. 5. For adults with severe or critical COVID-19…

… COVID-19, there is no drug certified to have considerable effects in the medical treatment for
COVID-19 … A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J …

… Our approach and that of other Covid-19 trials1 treat death as the worst outcome, and
data on deaths are censored at the end of follow-up. Hence, differences in mortality are …

… In this uncontrolled, exploratory study, 77 adults hospitalized with confirmed COVID-19
were treated with either nebulized IFN-α2b (5 mU bid), arbidol (200 mg tid) or a combination of …

… situation related to COVID-19 has led us to reconsider medical treatment alone for this …
with COVID-19 respond differently to antibiotic therapy and therefore, medical treatment of non-…

… mortality from COVID-19. We aimed to establish whether the addition of molnupiravir to usual
care reduced hospital admissions and deaths associated with COVID-19 in this population. …

… -use authorization for the treatment of adults and children with severe Covid-19 disease (5). …
the time to recovery in adults hospitalized with Covid-19 and evidence of lower respiratory …

… virus, termed coronavirus disease 19 or simply COVID-19, has … management strategies for
COVID-19 has been described. … is seen to be highly expressed in adult nasal epithelial cells. …

… Another prospective, randomized, controlled, open-label multicenter trial involving 240 adult
patients with COVID-19 from China was conducted to evaluate favipiravir vs. umifenovir for …